Clinical Trial Update: Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial update for a therapeutic DNA vaccine targeting herpes genitalis (HSV-2) has completed, reporting safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Genitalis

Drugs mentioned

• Vical HSV-2 therapeutic DNA vaccine (unknown)

Snippet

Sponsor: Vical | Conditions: Herpes Genitalis | Phase 2 | Status: COMPLETED